Skip to main content

Volume 7 - Issue 9 - September 2010

September 2010 Issue 9 Volume 7

John Laird, MD
Describe the inclusion criteria for patients in the RESILIENT trial Patients were included in the trial if they had lifestyle-limiting claudication (Rutherford categories 1–3) of at least 6 months’ duration and were candidates for angioplasty or st…
Clinical Review
Ali F. AbuRahma, MD
Introduction Seven million of the 25 million Americans with venous insufficiency exhibit serious symptoms such as edema, skin changes and venous ulcers.1 One million of these patients seek medical advice annually. Overall, 80% of patients with veno…
Special Focus: CLI
J. A. Mustapha, MD, FACC, FSCAI
Special Focus: CLI
Fahad G. Bitar, MD and Lawrence A. Garcia, MD
Peripheral arterial disease (PAD) represents a continuum of arterial obstructive syndromes that for the lower extremity ranges from the asymptomatic to limb loss. The overall prevalence of PAD has been estimated to be as high as 20% of the general po…
Special Focus: CLI
Lawrence A. Garcia, MD, FACC, FAHA
Identifying patients with critical limb ischemia and determining the most effective methods of therapy — either surgical or endovascular — pose great challenges. Eventually, we hope to see a robust set of clinical data that will allow us to effecti…
Back to Top